SC 13D

Company

BioAge Labs, Inc.

Filed

September 30, 2024

Accession Number

0001104659-24-104494

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →